| Innovations in human immunodeficiency virus (HIV) care delivery during the coronavirus disease 2019 (COVID-19) pandemic: policies to strengthen the ending the epidemic … WS Armstrong, AL Agwu, EP Barrette, RB Ignacio, JJ Chang, JA Colasanti, ... Clinical Infectious Diseases 72 (1), 9-14, 2021 | 56* | 2021 |
| Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy JA Hill, EM Krantz, KA Hay, S Dasgupta, T Stevens-Ayers, ... Blood advances 3 (22), 3590-3601, 2019 | 52 | 2019 |
| Drug combinations as a first line of defense against coronaviruses and other emerging viruses JM White, JT Schiffer, RA Bender Ignacio, S Xu, D Kainov, A Ianevski, ... MBio 12 (6), e03347-21, 2021 | 48 | 2021 |
| Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study M Massanella, RAB Ignacio, JR Lama, A Pagliuzza, S Dasgupta, R Alfaro, ... The Lancet Microbe 2 (5), e198-e209, 2021 | 40 | 2021 |
| Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020 * Shapiro, Adrienne E. MD, PhD1, * Bender Ignacio, Rachel A. MD, MPH1, ... JAIDS Journal of Acquired Immune Deficiency Syndromes, 2022 | 36 | 2022 |
| Hemophagocytic lymphohistiocytosis secondary to human immunodeficiency virus-associated histoplasmosis AA Castelli, DG Rosenthal, R Bender Ignacio, HY Chu Open forum infectious diseases 2 (4), ofv140, 2015 | 30 | 2015 |
| Symptom and viral rebound in untreated SARS-CoV-2 infection R Deo, MC Choudhary, C Moser, J Ritz, ES Daar, DA Wohl, AL Greninger, ... Annals of internal medicine 176 (3), 348-354, 2023 | 25 | 2023 |
| Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis C Ogimi, P Qu, M Boeckh, RAB Ignacio, SZ Zangeneh Epidemiology & Infection 149, e75, 2021 | 24 | 2021 |
| Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: a double-blind, randomized, cross-over trial RA Bender Ignacio, T Perti, AS Magaret, S Rajagopal, CE Stevens, ... The Journal of infectious diseases 212 (12), 1949-1956, 2015 | 24 | 2015 |
| HIV status and associated clinical characteristics among adult patients with cancer at the Uganda Cancer Institute R Bender Ignacio, M Ghadrshenas, D Low, J Orem, C Casper, W Phipps Journal of global oncology 4, 1-10, 2017 | 19 | 2017 |
| Clinical and immunologic outcomes after immediate or deferred antiretroviral therapy initiation during primary human immunodeficiency virus infection: the Sabes randomized … JR Lama, RAB Ignacio, R Alfaro, J Rios, JG Cartagena, R Valdez, C Bain, ... Clinical Infectious Diseases 72 (6), 1042-1050, 2021 | 18 | 2021 |
| HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru WL Trebelcock, JR Lama, A Duerr, H Sanchez, R Cabello, T Gilada, ... Journal of the International AIDS Society 22 (11), e25411, 2019 | 17 | 2019 |
| Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons RA Bender Ignacio, JD Goldman, AS Magaret, S Selke, ML Huang, ... Infectious agents and cancer 11 (1), 7, 2016 | 17 | 2016 |
| Recurrence of symptoms following a 2-day symptom free period in patients with COVID-19 DM Smith, JZ Li, C Moser, E Yeh, JS Currier, KW Chew, MD Hughes, ... JAMA Network Open 5 (10), e2238867-e2238867, 2022 | 16 | 2022 |
| Emergence of SARS-CoV-2 resistance with monoclonal antibody therapy MC Choudhary, KW Chew, R Deo, JP Flynn, J Regan, CR Crain, C Moser, ... medRxiv, 2021.09. 03.21263105, 2021 | 16 | 2021 |
| Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions EM Shelton, DB Reeves, RA Bender Ignacio AIDS Reviews, 2020 | 16 | 2020 |
| A population‐based study of perinatal infection risk in women with and without systemic lupus erythematosus and their infants RA Bender Ignacio, AT Madison, A Moshiri, NS Weiss, BA Mueller Paediatric and perinatal epidemiology 32 (1), 81-89, 2018 | 16 | 2018 |
| Safety and efficacy of combination SARS-CoV-2 neutralizing monoclonal antibodies amubarvimab plus romlusevimab in nonhospitalized patients with COVID-19 TH Evering, KW Chew, MJ Giganti, C Moser, M Pinilla, DA Wohl, ... Annals of internal medicine 176 (5), 658-666, 2023 | 14 | 2023 |
| Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection J Boucau, KW Chew, MC Choudhary, R Deo, J Regan, JP Flynn, ... Cell Reports Medicine 3 (7), 2022 | 13 | 2022 |
| Engagement in HIV Care and Access to Cancer Treatment Among Patients With HIV-Associated Malignancies in Uganda RABI Daniel H Low, Warren Phipps, Jackson Orem, Corey Casper Journal of Global Oncology, 1-8, 2019 | 12 | 2019 |
Sayan DasguptaSenior Staff Scientist, Fred Hutchinson Cancer CenterVerified email at fredhutch.org
